Application of the PGK-1 for Immuno-gene therapy of lung cancer
碩士 === 國立陽明大學 === 醫學生物技術研究所 === 93 === Abstract Although phosphoglycerate kinase 1 (PGK-1) catalyzes the conversion of 1,3-BPG to 3-PG and ATP in the cytosolic glycolytic pathway, it also acts as a disulphide reductase after secretion into the extracellular fluid in facilitating the reduction of pla...
Main Authors: | Huan-Chieh Cho, 卓煥傑 |
---|---|
Other Authors: | Kuang-Hui Sun |
Format: | Others |
Language: | zh-TW |
Published: |
2005
|
Online Access: | http://ndltd.ncl.edu.tw/handle/40849466100542792394 |
Similar Items
-
Effects of PGK-1 domains on the growth of lung carcinoma in vivo
by: Ying-Chun Lin, et al.
Published: (2007) -
Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis
by: Fei Shao, et al.
Published: (2019-10-01) -
Phylogenetic relationships in the genus Avena based on the nuclear Pgk1 gene.
by: Yuanying Peng, et al.
Published: (2018-01-01) -
Cloning and characterization of mouse PGK-1 promoter
by: 羅珮文
Published: (2006) -
Expression Characteristics and Significant Prognostic Values of PGK1 in Breast Cancer
by: Yanping Li, et al.
Published: (2021-07-01)